Schedule 13G ownership disclosure

AMPLIPHI BIOSCIENCES CORP

Security class unavailable · CUSIP: 03211P301

Event date: 2018-03-20

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
640,455
Percent of class
3.8900%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001535610-18-000071
Form type
SC 13G
Filer
Armata Pharmaceuticals, Inc.
CIK
CIK 921114
Filed
Mar 22, 2018
Reporting period
Mar 20, 2018
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub